Impact of Dexmedetomidine Infusion on Postoperative Acute Kidney Injury in Elderly Patients Undergoing Major Joint Replacement: A Retrospective Cohort Study

• Main Authors: Zhu H, Ren A, Zhou K, Chen Q, Zhang M, Liu J
• Format: Article
• Language: English
• Published: Dove Medical Press 2020-11-01
• Series: Drug Design, Development and Therapy
• Subjects: dexmedetomidine; acute kidney injury; elderly patients; joint replacement
• Online Access: https://www.dovepress.com/impact-of-dexmedetomidine-infusion-on-postoperative-acute-kidney-injur-peer-reviewed-article-DDDT

He Zhu,1 Aolin Ren,1 Kang Zhou,1 Qiuchong Chen,1 Mengjun Zhang,1 Jindong Liu2 1Jiangsu Province Key Laboratory of Anesthesiology, Xuzhou Medical University, Xuzhou, Jiangsu, People’s Republic of China; 2Department of Anesthesiology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, People’s Republic of ChinaCorrespondence: Jindong LiuDepartment of Anesthesiology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, People’s Republic of China, Tel [phone]Email [e-mail]: Postoperative acute kidney injury (AKI) is a frequent complication in elderly patients that increases morbidity and mortality. Approximately 1.7 million people die from AKI worldwide every year. Dexmedetomidine (Dex) is often used as an adjunct to multimodal analgesia. Our study investigated whether Dex could safely decrease the incidence of AKI in elderly patients undergoing major joint replacement.Methods: A single-center retrospective study was conducted in patients aged > 65 years undergoing major joint replacement. Propensity score–matching analysis was used, and a total of 1,006 patients were matched successfully. The primary outcome was the incidence of postoperative AKI. Secondary outcomes included perioperative adverse complications, opioid consumption, time to extubation, and length of hospital stay.Results: Among the 1,006 patients included, postoperative AKI occurred in 9.3% (n=94). The Dex group (perioperative Dex infusion) had lower incidence of postoperative AKI than the control group (7.2% vs 11.5%, P=0.017). Compared with the control group, the Dex group had less opioid consumption (P< 0.05), reduced time to extubation (P=0.004), and shorter length of hospital stay (P=0.001). The Dex group also showed higher incidence of bradycardia (20.1% vs 15.1%, P=0.038). There were no differences in intraoperative hypotension (19.5% vs 17.5%), postoperative nausea and vomiting (4.2% vs 5.4%), time in PACU (45.0± 6.4 vs 45.5± 6.2 minutes), or rate of ICU admission (9.7% vs 11.1%) between the Dex group and control group (All P> 0.05).Conclusion: This retrospective study showed Dex infusion in elderly patients undergoing major joint replacement was associated with lower incidence of postoperative AKI, less opioid consumption, and shorter extubation time and hospital stay. However, the Dex group had higher incidence of bradycardia. We found no statistical differences in other perioperative adverse complications between the groups.Keywords: dexmedetomidine, acute kidney injury, elderly patients, joint replacement